Member Info for olderbutwiser

Why does LSE not show all trades? It often does not show trades from late in the afternoon and did/ does not show the 2,800,000 buy at 1.325p at 17.06 on 27-09-2021 buy that Soup refers to either.
The London Stock Exchange site clearly shows it currently, see https://www.londonstockexchange.com/stock/NFX/nuformix-plc/company-page

Oh forgot to say.
At some point after they start discussions with the drug originator then the need for commercial secrecy presumably goes and only then could they inform shareholders of the drug involved.

Hi Soup interesting comments re potential dru, etc
Just to add to your comments on NXP004.
I was informed a while ago, from communications with Nuformix, that if the results of the research study were positive Nuformix would be submitting a further patent, and that as soon as the patent submission was filed they would be in a position to start discussions with the drug originator - they would not have to wait the further 18 months or so for the patent to be granted before talking to the drug originator.
So, I wonder if they could already have those results (either preliminary or full results) and JH may already be working with AB on a patent application. So may just depend upon how long the patent search and submission process takes before deal negotiations for NXP004 can start. Presumably much of the patent work could have been done in anticipation of positive results - but that may be my wishful thinking.

Oxilio deal agreed and signed - finally!
Good to see some share buying from the Chairman.
Also good to see Proactive interview with Anne.
Both indicate , directly or indirectly, that 004 and 002 studies are progressing well - these are the potential game-changers for Nuformix.
Just need the sp to reflect the news and the potential here.
GLA

I think the new BOD are being deliberately cautious in their statements, partly due to their background but largely due to the over-optimistic statements made by DG which must be haunting them.
They are certainly keeping their cards close to their chests.
Could be that if I and others had attended the AGM we might have got a better feel for the situation.
From previous attendance at company AGM's I have found that things are often said in the questions session or even informally that do not get reported, it might just be a small comment but it can sometimes be very telling if the directors are in a talkative mood. Oh well opportunity lost.
Anyway some good news in there.
GLA

Are these really all the questions and answers?
They appear to have been written to deliberately avoid giving anything away.
However the major positive I take from these is that the 002 and 004 studies are going well with positive results so far, and I guess that they must be in the final straight now. So looks promising. I am hoping for positive 004 RNS say in about 6 weeks and a positive 002 RNS in about 10 weeks for both the studies - although I would prefer if they could RNS them earlier separately.

Hi Sentiment-Attack
'They have been pacified and their outlook excellent imo'
Who are 'they' and what makes you think ' their outlook excellent '?
Just curious.
ATB

I agree with the general comments - a sad situation.
But looking at many pharma stocks they are down to about half of what they were 6 months ago, or even 3 months ago.
Here the total lack of news and optimism are taking their toll here.
Are we at/ close to the bottom?
Hoping that AGM comes to the rescue with some positive news flow being released .

The level of posts has hit rock bottom here.
The SFO - oh yes and the Sweeney whilst your at it.
But at least point out the true outlaws - DT and AC who slyly bailed under questionable circumstances.
To a lesser extent there is Dan who, had he been more experienced, would have done a large placing in Q4 2019 (10% to 20% placing) and who's hubris led us into these difficulties by not creating contingency funds to undertake an alternative path when the 'guaranteed' NXP002 negotiations stalled in early 2020. However incompetence is not usually a crime.
But Anne Brindley only joined after the damage had been well and truly done. She has done what Nuformix needed and if the results are as she, the bod and the shareholders hope for then it will trigger negotiations for NXP002 and NXP004 and a humungous rise in the share price from this parlous state.
Here's hoping.

This is a bit different to before.
Before there was the looming deadline for Oxilio to confirm they would be taking up the option in conjunction with the twitter crowd pumping the sp to enable the lucky 2p new shareholders to exit with a quick profit.
Now, assuming there are no leaks, there is nothing to give us a heads up to what news may be coming.
We can only hope that Oxilio deal finalises and that we get a good positive update on the NXP004 and NXP002 work in progress.
Here's hoping for some positive surprises - we deserve it.
ATB

Thanks FFXS
Unfortunately my broker is not so helpful. I will have to ring them to get a letter of confirmation of holding.
Thanks anyway.

By the way, I am certainly not saying we are worth £300m.
I am saying there are pharma companies out there with similar skeleton (virtual) management and employee situations who are doing very well.
We need the positive study results to trigger deal discussions, as per Alistair Riddell interview, and investor confidence.
SO if the study results in a few months time are positive then we are certainly worth a lot more than our current paltry £8m, several times more I believe.
Sorry for hurried messages - but juggling lots of stuff.

I will get letter from brokers just in case I can make it to the AGM. Although does not say need one.
Is anyone else likely to be going?

Just a thought .
Someone posted on twitter a couple of weeks ago about similarities between SAR and NFX in the fact that they also are just a few chiefs (5) and just one indian (1) and have little in the way of cash and outsource all their studies.
SAR are worth £300m having X5 in the last few months and NFX are £8m.
Now IF the Nxp002 studies and NXp004 study are positive ......... well who knows - can but dream.
GLA

Thanks Soup. Does not seem to state what requirements for attending the AGM are. Do we need to take a letter from our brokers confirming our shareholding as most AGM's require - certainly if wish to vote?

What is the requirement for attending the AGM on 24th August .
For some reason (probably stupidity) I cannot locate the detailed AGM info.
Thanks.

It does sound like potential partners/ buyers already have their sights on Nuformix and if the expected results are achieved in the studies then that will trigger negotiations.
I believe Anne and the board will be formulating a preliminary negotiation framework over the coming months in anticipation of good results - Julian Gilbert has very useful experience in this area.
GLA

Tend to agree Whimax.
ForFXSake pull yourself together.
Anne got funding to see us through the structured data studies and to negotiations. Several studies for NXP002 and NXP004 are well under way. The structured data programme will be largely in place or done by the time she departs. Her successor will probably be chosen because they endorse and will build on the structured data programme she has initiated.

The company is in safe hands for the next 6 months with Anne largely finishing what she has instigated - Joanne Holland is in a supporting role.
The company has funds for the next year or more - enough to get through the pre-clinical studies and to being able to discuss with potential partners.
There are 6 months to get a new suitable CEO in place.
Can but cross fingers and hope that things come together over the next 6 months.
GLA

Exactly Mozax
Anne sees the fruits of her recent NFX work through to success - then moves to fantastic new job.
I can guarantee that if there was any hint that things were not going well/ as planned then she would not be staying for 6 months.